MMRF ASH 2023 Blog: ASH Day 2
December 13, 2023
December 13, 2023
NORWALK, Connecticut, Dec. 13 -- The Multiple Myeloma Research Foundation issued the following news:
Day 2 of ASH represented the calm before the storm, as only a couple of abstracts on myeloma were featured on Sunday compared to the more than a dozen presentations that will be highlighted on Day 3. Updates from Day 2 included a real-world comparison of quadruplet versus triplet regimens in standard- and high-risk newly diagnosed multiple myeloma and an assessment of the real-world . . .
Day 2 of ASH represented the calm before the storm, as only a couple of abstracts on myeloma were featured on Sunday compared to the more than a dozen presentations that will be highlighted on Day 3. Updates from Day 2 included a real-world comparison of quadruplet versus triplet regimens in standard- and high-risk newly diagnosed multiple myeloma and an assessment of the real-world . . .